Looks Health

  • Market Cap: Micro Cap
  • Industry: Healthcare Services
  • ISIN: INE204N01013
  • NSEID:
  • BSEID: 534422
INR
3.84
0.00 (0.00%)
BSENSE

Dec 04

BSE+NSE Vol: 2.39 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

2.39 k (-90.54%) Volume

Shareholding (Jun 2025)

FII

6.93%

Held by 1 FIIs

DII

0.00%

Held by 0 DIIs

Promoter

13.31%

How has been the historical performance of the Looks Health?

07-Jun-2025

Looks Health has experienced a significant decline in net sales from Rs 1.14 crore in March 2019 to Rs 0.39 crore in March 2025, with negative operating profit margins for most years, though recent signs of recovery in profits are noted. Total assets have slightly decreased, and cash flow activities have remained stagnant.

Answer:<BR>The historical performance of Looks Health shows a fluctuating trend in its financial metrics over the years, with notable changes in net sales, profits, and expenses.<BR><BR>Breakdown:<BR>Looks Health's net sales have seen a significant decline from Rs 1.14 crore in March 2019 to Rs 0.39 crore in March 2025, with several years recording negligible sales. The total operating income followed a similar pattern, peaking at Rs 0.78 crore in March 2020 before dropping to Rs 0.39 crore in March 2025. The company has consistently reported no raw material costs, but employee costs have increased from Rs 0.64 crore in March 2019 to Rs 0.34 crore in March 2025. Operating profit margins have been negative for most years, with a notable -58.97% in March 2025, while the gross profit margin improved to 41.03% in the same year. Profit before tax showed a recovery to Rs 0.03 crore in March 2025 after several years of losses, and profit after tax also turned positive at Rs 0.02 crore. The company's total liabilities have remained relatively stable, with total assets slightly declining from Rs 15.36 crore in March 2019 to Rs 14.85 crore in March 2024. Cash flow activities have been stagnant, with no cash inflow or outflow reported across the years. Overall, Looks Health has faced challenges in maintaining sales and profitability, but recent signs of recovery in profits may indicate a potential turnaround.

Read More

how big is Looks Health?

06-Jun-2025

As of Jun 06, Looks Health Services Ltd has a market capitalization of 5.25 Cr, with net sales of 0.39 Cr and a net profit of 0.03 Cr over the latest four quarters. The standalone balance sheet shows shareholder's funds of 14.80 Cr and total assets of 14.85 Cr.

As of Jun 06, Looks Health Services Ltd has a market capitalization of 5.25 Cr, classifying it as a Micro Cap company.<BR><BR>As of Jun 06, the company reported a sum of Net Sales for the latest 4 quarters amounting to 0.39 Cr and a sum of Net Profit of 0.03 Cr. This data is based on Standalone financials.<BR><BR>As of Mar 24, the Standalone balance sheet shows Shareholder's Funds of 14.80 Cr and Total Assets of 14.85 Cr.

Read More

What does Looks Health do?

06-Jun-2025

Looks Health Services Ltd specializes in surgical and non-surgical cosmetic and aesthetic treatments. As of March 2025, the company reported net sales and net profit of 0 Cr, with a market cap of Rs 5 Cr.

Overview: <BR>Looks Health Services Ltd operates in the healthcare services industry, specializing in both surgical and non-surgical cosmetic and aesthetic treatments.<BR><BR>History: <BR>The company was incorporated in October 2011 under the name 'Monarch Health Services Limited' and changed its name to 'Looks Health Services Limited' in March 2013. The latest quarterly results reported net sales and net profit of 0 Cr for the period ending March 2025.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 0 Cr (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: 0 Cr (Quarterly Results - Mar 2025) <BR>Market-cap value: Rs 5 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 5.00 <BR>Industry P/E: 54 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: -0.02 <BR>Return on Equity: 0.20% <BR>Price to Book: 0.36 <BR><BR>Contact Details: <BR>Address: A/203 Green Villa above pizza, Lokhandwala Complex Andheri(W) Mumbai Maharashtra : 400053 <BR>Tel: 91-22-42952616 <BR>Email: cs@looksclinic.com <BR>Website: http://www.looksclinic.in

Read More

What is the bonus history of the Looks Health?

06-Jun-2025

Looks Health issued a 3:4 bonus on October 29, 2015, with a record date of October 30, 2015, allowing eligible shareholders to receive additional shares based on that ratio.

Looks Health has a history of issuing bonuses, with the most recent being a 3:4 bonus issue announced on October 29, 2015. The record date for this bonus was October 30, 2015. This means that shareholders on record as of that date would have received additional shares based on the specified ratio. If you have any more questions about Looks Health or its financial activities, feel free to ask!

Read More

Has Looks Health declared dividend?

06-Jun-2025

No Dividend History Available

Who are the peers of the Looks Health?

03-Jun-2025

Looks Health's peers include Syngene Intl., Dr Lal Pathlabs, Poly Medicure, Indegene, Vijaya Diagnost., Metropolis Healt, Thyrocare Tech., Suven Life Scie., and Dr Lalchand. Lab. Suven Life Scie. leads in 1-year returns at 160.99%, while Dr Lalchand. Lab has the lowest at -42.86%, with Looks Health's return at -14.13%.

Peers: Looks Health's peers are Syngene Intl., Dr Lal Pathlabs, Poly Medicure, Indegene, Vijaya Diagnost., Metropolis Healt, Thyrocare Tech., Suven Life Scie., and Dr Lalchand. Lab.<BR><BR>Quality Snapshot: Excellent management risk is observed at Dr Lal Pathlabs, while Good management risk is found at Syngene Intl., Poly Medicure, Indegene, Vijaya Diagnost., Metropolis Healt, and Thyrocare Tech., and the rest. Average management risk is present at Dr Lalchand. Lab, while Below Average management risk is noted for Suven Life Scie. Growth is Below Average for Syngene Intl., Dr Lal Pathlabs, Vijaya Diagnost., Metropolis Healt, Thyrocare Tech., and Dr Lalchand. Lab, while Average growth is seen at Poly Medicure and Indegene, and the rest. Suven Life Scie. shows Below Average growth. <BR><BR>Return Snapshot: Suven Life Scie. has the highest 1-year return at 160.99%, while Dr Lalchand. Lab has the lowest at -42.86%, with Looks Health's own 1-year return at -14.13% being significantly better than Dr Lalchand. Lab's but worse than Suven Life Scie.'s. Additionally, Metropolis Healt, Dr Lalchand. Lab, and Syngene Intl. have negative six-month returns.

Read More

Is Looks Health overvalued or undervalued?

09-Jun-2025

As of April 25, 2023, Looks Health is considered overvalued and risky, with a low PE ratio of 5.25 and negative EV to EBITDA, despite a recent one-month stock return of 8.89%, which contrasts with its troubling one-year return of -10.09%.

As of 25 April 2023, Looks Health's valuation grade has moved from does not qualify to risky, indicating a significant shift in its perceived financial health. The company is currently assessed as overvalued, with a PE ratio of 5.25, an EV to EBITDA of -4.94, and a PEG ratio of 0.02, all of which suggest that the stock may not be a sound investment relative to its peers.<BR><BR>In comparison to its industry, Looks Health's PE ratio is starkly lower than that of Max Healthcare at 100.29 and Apollo Hospitals at 69.03, both of which are considered very expensive. Furthermore, the company's negative EV to EBITDA ratio highlights underlying operational challenges. Despite a recent one-month stock return of 8.89%, which outperformed the Sensex's 3.87%, the longer-term performance shows a concerning trend, with a one-year return of -10.09% compared to the Sensex's 7.61%. This reinforces the view that Looks Health is currently overvalued in the market.

Read More

What is the technical trend for Looks Health?

09-Jun-2025

As of June 6, 2025, Looks Health's trend is neutral with mixed indicators, showing a shift from mildly bearish to sideways, as weekly signals are mildly bullish while daily and monthly indicators suggest weakness and uncertainty.

As of 6 June 2025, the technical trend for Looks Health has changed from mildly bearish to sideways. The current stance is neutral, with mixed indicators influencing the outlook. The weekly MACD and Dow Theory are both mildly bullish, suggesting some positive momentum, while the daily moving averages indicate a mildly bearish trend. The Bollinger Bands show a bullish signal on the weekly chart but are mildly bearish on the monthly. The KST is mildly bullish weekly but bearish monthly, and the RSI shows no signal in both time frames. Overall, the strength of the trend is weak, reflecting uncertainty in the market.

Read More

Who are in the management team of Looks Health?

16-Jul-2025

As of March 2022, the management team of Looks Health includes Pritesh Champalal Doshi (Chairperson & Managing Director), Kanchan Kaku (Company Secretary & Compliance Officer), Sejal Jain, and Devendra Sanghvi (both Independent Directors). They are responsible for the company's governance and oversight.

As of March 2022, the management team of Looks Health consists of the following individuals:<BR><BR>1. Pritesh Champalal Doshi - Chairperson & Managing Director<BR>2. Kanchan Kaku - Company Secretary & Compliance Officer<BR>3. Sejal Jain - Independent Director<BR>4. Devendra Sanghvi - Independent Director<BR><BR>These members play key roles in the governance and oversight of the company.

Read More

Who are the top shareholders of the Looks Health?

17-Jul-2025

The top shareholders of Looks Health are Maxgainz Finserve Private Limited with 13.09%, Wave Capital Ltd and a foreign institutional investor each holding 6.93%, while individual investors collectively own 75.82% of the shares. There are no pledged promoter holdings or mutual fund investments in the company.

The top shareholders of Looks Health include Maxgainz Finserve Private Limited, which holds the highest promoter stake at 13.09%. Additionally, Wave Capital Ltd is the highest public shareholder, owning 6.93%. The company also has one foreign institutional investor (FII) holding 6.93%. Individual investors collectively hold a significant portion, accounting for 75.82% of the shares. There are no pledged promoter holdings, and no mutual funds are currently invested in the company.

Read More

When is the next results date for Looks Health?

29-Oct-2025

Looks Health will declare its results on 30 October 2025.

Looks Health will declare its results on 30 October 2025.

Read More

Which are the latest news on Looks Health?

04-Dec-2025

Why is Looks Health falling/rising?

04-Dec-2025

As of 04-Dec, Looks Health Services Ltd's stock price is Rs. 3.84, down 2.78%, and has underperformed significantly with a year-to-date decline of 24.56%. The stock is trading below its moving averages and has seen a drastic drop in investor participation, indicating ongoing challenges.

As of 04-Dec, Looks Health Services Ltd is experiencing a decline in its stock price, currently at Rs. 3.84, which reflects a change of -0.11 (-2.78%). This downward movement is supported by several factors. The stock has underperformed significantly over various time frames, with a year-to-date decline of -24.56% compared to a +9.12% increase in the Sensex. Additionally, the stock has hit a new 52-week low of Rs. 3.76 today and has been on a consecutive fall for the last three days, resulting in a total decline of -4.95% during this period.<BR><BR>The stock is also trading below its moving averages across multiple time frames, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating a bearish trend. Furthermore, there has been a significant drop in investor participation, with delivery volume falling by -81.31% against the 5-day average. This lack of interest from investors, combined with the stock's poor performance relative to the sector, suggests that Looks Health is facing challenges that are contributing to its declining stock price.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Healthcare Services

stock-summary
Market cap

INR 4 Cr (Micro Cap)

stock-summary
P/E

134.00

stock-summary
Industry P/E

64

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.02

stock-summary
Return on Equity

0.20%

stock-summary
Price to Book

0.28

Revenue and Profits:
Net Sales:
0 Cr
(Quarterly Results - Jun 2025)
Net Profit:
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
0%
0%
0.0%
6 Months
-23.96%
0%
-23.96%
1 Year
-23.2%
0%
-23.2%
2 Years
-29.15%
0%
-29.15%
3 Years
-49.14%
0%
-49.14%
4 Years
-76.44%
0%
-76.44%
5 Years
144.59%
0%
144.59%

Looks Health for the last several years.

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions
News

Why is Looks Health falling/rising?

Recent Price Movement and Market Context

Looks Health’s share price has been under pressure, losing 14.06% over the past week, in stark contrast to the Sensex’s modest gain of 0.56% during the same period. The stock’s year-to-date performance remains weak, down 24.36%, while the Sensex has advanced by 9.68%. Over the last one year, Looks Health has declined 23.00%, whereas the benchmark index has risen 8.43%. This divergence highlights the stock’s sustained underperformance relative to the broader market.

Moreover, the stock is trading perilously close to its 52-week low, just 1.04% above the bottom price of ₹3.81. This proximity to the yearly low signals persistent selling pressure and a lack of upward momentum. The recent two-day consecutive fall has resulted in a cu...

Read More
Announcements stock-summary

Intimation Of Submission Of Application To BSE Limited For Reclassification Of Promoters From The Promoter Group To The Public Category

03-Dec-2025 | Source : BSE

Intimation of submission of Application for Reclassification under Regulation 31(A) of SEBI (LODR) Regulations 2015

Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)

02-Dec-2025 | Source : BSE

In addition to Board Meeting Outcome filed for Board Meeting held on December 01 2025. Please find attached the Additional Details required as per SEBI Circular. Kindly note the same was also filed with BSE on 19.11.2025.

Announcement under Regulation 30 (LODR)-Change in Management

02-Dec-2025 | Source : BSE

In addition to Board Meeting outcome filed for Board meeting held on December 01 2025 Please find herewith the Additional Details required under SEBI Circular dated November 11 2024 for Corporate Announcements filed under Regulation 30 of SEBI (LODR) Regulations 2015. Kindly note the same was also filed with BSE Limited on November 19 2025.

Corporate Actions stock-summary
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

Looks Health Services Ltd has announced 3:4 bonus issue, ex-date: 29 Oct 15

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
-9.12%
EBIT Growth (5y)
4.40%
EBIT to Interest (avg)
0
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.02
Sales to Capital Employed (avg)
0
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
6.93%
ROCE (avg)
-3.53%
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
134
Industry P/E
64
Price to Book Value
0.27
EV to EBIT
-3.72
EV to EBITDA
-3.72
EV to Capital Employed
0.26
EV to Sales
3.72
PEG Ratio
0.54
Dividend Yield
NA
ROCE (Latest)
-2.48%
ROE (Latest)
0.20%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Jun 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Non Institution

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 1 FIIs (6.93%)

Promoter with highest holding

Maxgainz Finserve Private Limited (13.09%)

Highest Public shareholder

Wave Capital Ltd (6.93%)

Individual Investors Holdings

75.82%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Jun 2024",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 100.00% vs 0.00% in Jun 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.07",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.04",
          "val2": "-0.13",
          "chgp": "130.77%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "0.00",
          "val2": "-0.05",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "57.14%",
          "val2": "0.00%",
          "chgp": "57.14%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is 0.00% vs -100.00% in Sep 2023",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is 0.00% vs -100.00% in Sep 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.30",
          "val2": "-0.16",
          "chgp": "-87.50%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-0.13",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 0.00% vs -100.00% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -1,500.00% vs -150.00% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.41",
          "val2": "-0.25",
          "chgp": "-64.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-0.16",
          "val2": "-0.01",
          "chgp": "-1,500.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is 0.00% vs -100.00% in Mar 2024",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is 200.00% vs 87.50% in Mar 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.39",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.23",
          "val2": "-0.34",
          "chgp": "32.35%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "0.02",
          "val2": "-0.02",
          "chgp": "200.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-58.97%",
          "val2": "0.00%",
          "chgp": "-58.97%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Standalone) - Jun'25 - YoYstock-summary
Jun'25
Jun'24
Change(%)
Net Sales
0.07
0.00
Operating Profit (PBDIT) excl Other Income
0.04
-0.13
130.77%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Standalone Net Profit
0.00
-0.05
100.00%
Operating Profit Margin (Excl OI)
57.14%
0.00%
57.14%
Values in Rs Cr.
Net Sales

YoY Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Jun 2024

Direction Arrows
Standalone Net Profit

YoY Growth in quarter ended Jun 2025 is 100.00% vs 0.00% in Jun 2024

Half Yearly Results Snapshot (Standalone) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-0.30
-0.16
-87.50%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Standalone Net Profit
-0.13
0.00
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is 0.00% vs -100.00% in Sep 2023

Direction Arrows
Standalone Net Profit

Growth in half year ended Sep 2024 is 0.00% vs -100.00% in Sep 2023

Nine Monthly Results Snapshot (Standalone) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-0.41
-0.25
-64.00%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Standalone Net Profit
-0.16
-0.01
-1,500.00%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 0.00% vs -100.00% in Dec 2023

Direction Arrows
Standalone Net Profit

YoY Growth in nine months ended Dec 2024 is -1,500.00% vs -150.00% in Dec 2023

Annual Results Snapshot (Standalone) - Mar'25stock-summary
Mar'25
Mar'24
Change(%)
Net Sales
0.39
0.00
Operating Profit (PBDIT) excl Other Income
-0.23
-0.34
32.35%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Standalone Net Profit
0.02
-0.02
200.00%
Operating Profit Margin (Excl OI)
-58.97%
0.00%
-58.97%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2025 is 0.00% vs -100.00% in Mar 2024

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2025 is 200.00% vs 87.50% in Mar 2024

stock-summaryCompany CV
About Looks Health Services Ltd stock-summary
stock-summary
Looks Health Services Ltd
Micro Cap
Healthcare Services
Looks Health Services Limited, which formerly incorporated in the name of 'Monarch Health Services Limited' in October, 2011 was changed to the present name 'Looks Health Services Limited' in March, 2013. Looks Cosmetic Clinic is India's first ever clinic with the pioneering concept of a single clinic equipped for both surgical and non-surgical cosmetic and aesthetic treatments.
Company Coordinates stock-summary
Company Details
A/203 Green Villa above pizza, Lokhandwala Complex Andheri(W) Mumbai Maharashtra : 400053
stock-summary
Tel: 91-22-42952616
stock-summary
cs@looksclinic.com
Registrar Details
Skyline Financial Services Pvt Ltd , D-153/A, 1st Floor, Okhla Industrial Area, Phase - I, New Delhi